OKYO Pharma (OKYO) Operating Leases (2021)
OKYO Pharma (OKYO) reported Operating Leases of $98760.0 for Q1 2021.
OKYO Pharma (OKYO) Operating Leases (2021) Analysis & Trends
OKYO Pharma (OKYO) has 1 years of Operating Leases data on file, last reported at $98760.0 in Q1 2021.
- Operating Leases for Q1 2021 came in at $98760.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $98760.0 (changed N/A YoY), and the FY2021 annual result was $98760.0, changed N/A from the prior year.
- Operating Leases steadied at $98760.0 in Q1 2021 per OKYO's latest filing.
- Over five years, Operating Leases peaked at $98760.0 in Q1 2021 and troughed at $98760.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | OKYO Pharma | 244.98 Mn | 240.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 98,760.00 |